tiprankstipranks
Advertisement
Advertisement
Jasper Therapeutics downgraded to Hold from Buy at TD Cowen
PremiumThe FlyJasper Therapeutics downgraded to Hold from Buy at TD Cowen
18d ago
Jasper Therapeutics price target lowered to $7 from $12 at Evercore ISI
Premium
The Fly
Jasper Therapeutics price target lowered to $7 from $12 at Evercore ISI
2M ago
Jasper Therapeutics’ Deep Cuts May Backfire: Analyst Warns Downsizing Could Undermine Briquilimab Strategy and Cash Runway
Premium
Company Announcements
Jasper Therapeutics’ Deep Cuts May Backfire: Analyst Warns Downsizing Could Undermine Briquilimab Strategy and Cash Runway
2M ago
Jasper Therapeutics initiated with a Buy at Rodman & Renshaw
PremiumThe FlyJasper Therapeutics initiated with a Buy at Rodman & Renshaw
5M ago
Briquilimab’s Robust Efficacy and Favorable Safety in Urticaria Indicate Strong Upside for Jasper Therapeutics and Support a Buy Rating
Premium
Ratings
Briquilimab’s Robust Efficacy and Favorable Safety in Urticaria Indicate Strong Upside for Jasper Therapeutics and Support a Buy Rating
5M ago
Jasper Therapeutics Reports Strong Briquilimab Data in Urticaria
Premium
Company Announcements
Jasper Therapeutics Reports Strong Briquilimab Data in Urticaria
5M ago
3 Penny Stocks to Watch Now, 12/4/25
PremiumMarket News3 Penny Stocks to Watch Now, 12/4/25
6M ago
Positive Outlook for Jasper Therapeutics: Buy Rating Reinforced by Briquilimab’s Promising Data and Strategic Plans
Premium
Ratings
Positive Outlook for Jasper Therapeutics: Buy Rating Reinforced by Briquilimab’s Promising Data and Strategic Plans
6M ago
Jasper Therapeutics: Strategic Patient Selection and Consistent Drug Performance Justify Buy Rating
Premium
Ratings
Jasper Therapeutics: Strategic Patient Selection and Consistent Drug Performance Justify Buy Rating
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100